Plant products, namely, live transgenic plants, dried transgenic plants, and transgenic plant seeds
On Friday, March 3, 2006, a trademark application was filed for GEOGENETICS with the United States Patent and Trademark Office. The USPTO has given the GEOGENETICS trademark a serial number of 78828819. The federal status of this trademark filing is ABANDONED – FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, May 21, 2009. This trademark is owned by GeoGenetics Inc.. The GEOGENETICS trademark is filed in the Natural Agricultural Products and Computer & Software Services & Scientific Services categories with the following description:
Scientific research for others in the field of genetic engineering, genetic engineering development services for others, namely, developing transgenic plants and seeds
Additionally, our Cannabis seeds are always fresh and never purchased as bulk material. We only sell quality goods, assessing every seed before shipping. This is why we can guarantee that only seeds with the highest quality are delivered to our customers.
Depending on the space you have available you can choose between species that flourish best outdoors or in an enclosed space. Outdoor strands usually grow a lot bigger, thrive best in a natural habitat and are very robust. Indoor seeds are specifically convenient if one does not have a lot of space for the cultivation. Both types germinate particularly well indoors, safe from temperature drops or other environment changes. If you are looking to buy Marijuana for indoor growth, we recommend Big Bud, Amnesia, or White Widow. They are the bestsellers in our online shop. Indoor species like a steady temperature and humidity level and their growth and blooming can easily be influenced by regulating the lighting times.
Marijuana seeds for indoor and outdoor cultivation
Established in 2006, High Supplies has been cultivating a love for cannabis culture as well as cannabis seeds. We offer over 50 different varieties of marijuana seeds.
Regular, feminized, and auto-flowering Cannabis Seeds from the Netherlands
Illumina (NASDAQ:ILMN) and the Lundbeck Foundation GeoGenetics Centre at the University of Copenhagen, Denmark partner to explore the relationship between the evolutionary history of select mental and neurological disorders and infectious pathogens. One of the first projects of its kind worldwide, the endeavor aims to acquire new knowledge in terms of the medical and biological understanding of special factors underlying the development of human neuropsychiatric diseases through the ages. Ultimately, the project may provide a new approach to the development of medicines and other therapeutic treatments for mental and neurological conditions.
The international, multi-disciplinary team of scientists, which includes specialists in ancient genomics, neuro-genetics, population genetics, archaeology, linguistics, and experts in brain health, among others, will focus on creating two unique subsets of genomic data. The first panel is a 5,000 ancient human genomes panel. The second panel will consist of ancient pathogen DNA that is associated with human diseases. Both panels, which will be made publicly available, will together advance our understanding of the evolution of disease variance and its interaction with the human genome and pathogen pressure. The project will generate and analyze one of the largest sets of ancient human and pathogen genome panels ever created.
In order to decode the genetic origins and evolution of human diseases, Professor Willerslev and his team will utilize Illumina’s most powerful sequencer, the NovaSeq™6000 System, which was designed to open new horizons for larger, more robust experiments, providing the throughput to properly power large-cohort studies. Projects of this scale benefit from speed, throughput and data quality, and as such this project will leverage the S4 flow cell to sequence up to 20 billion ancient DNA fragments every two days.
“Over the past 10,000 years, mankind has experienced some of the greatest lifestyle changes in the history of our species,” said Professor Willerslev, Lundbeck Foundation Professor at the University of Copenhagen and Prince Philip Professor at the University of Cambridge. “Our diet changed as we developed from hunter-gatherers into farmers, our settlement patterns changed, and there have been changes in pressure of infection from the pathogenic micro-organisms to which we were exposed due to altered living conditions. We also know that chronic viral, bacterial and fungal infections might be causative factors in neuropsychiatric diseases, so there is every reason to believe that the analyses of DNA from this period will show significant trends, giving us the ability to create new, publicly available reference sets, to enhance both the scientific and healthcare communities’ understanding of disease evolution.”